In addition, CD8+ TRegs were elevated in stromal lymph aggregates (Figure 5A), while CD4+ TRegs were also elevated at NOS2+ tumor edges when compared with tumor satellite and/or core regions (Figure 5B). The gene discussed is CD4; the disease is neoplasm.